FRESH TRACKS THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FRTX and buy or sell other stocks, ETFs, and their options commission-free!About FRTX
Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis.
CEOAlbert N. Marchio, II, MBA
CEOAlbert N. Marchio, II, MBA
Employees—
Employees—
HeadquartersBoulder, Colorado
HeadquartersBoulder, Colorado
Founded2009
Founded2009
Employees—
Employees—
FRTX Key Statistics
Market cap5.59M
Market cap5.59M
Price-Earnings ratio-0.66
Price-Earnings ratio-0.66
Dividend yield—
Dividend yield—
Average volume1.79K
Average volume1.79K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.03
52 Week high$1.03
52 Week low$0.03
52 Week low$0.03
Stock Snapshot
As of today, FRESH TRACKS THERAPEUTICS(FRTX) shares are valued at $0.94. The company's market cap stands at 5.59M, with a P/E ratio of -0.66.
On 2025-12-05, FRESH TRACKS THERAPEUTICS(FRTX) stock opened at —, reached a high of —, and a low of —.
The FRESH TRACKS THERAPEUTICS(FRTX)'s current trading volume is 0, compared to an average daily volume of 1.79K.
In the last year, FRESH TRACKS THERAPEUTICS(FRTX) shares hit a 52-week high of $1.03 and a 52-week low of $0.03.
In the last year, FRESH TRACKS THERAPEUTICS(FRTX) shares hit a 52-week high of $1.03 and a 52-week low of $0.03.
People also own
Based on the portfolios of people who own FRTX. This list is generated using Robinhood data, and it’s not a recommendation.